Clinical Evidence Mendability has a clinically validated approach with a recent trial showing meaningful behavioral and cognitive improvements in children, suggesting credible value to funders, clinics, and insurers seeking evidence-based autism therapies.

Telehealth Advantage As a telehealth provider of Sensory Enrichment Therapy, Mendability can scale outreach beyond local geography, offering remote programs to pediatric clinics, schools, and a broader network of caregivers seeking accessible autism interventions.

Parental Engagement Therapy protocols rely on parents or therapists administering exercises, presenting an opportunity to partner with parent organizations, respite care providers, and caregiver support communities for co-marketing and training programs.

Cost-Effective Solution Position Mendability as a cost-effective alternative or complement to pharmaceutical options, appealing to healthcare systems, insurers, and school districts looking to invest in scalable neurodevelopmental therapies with measurable outcomes.

Growth Readiness With revenue in the low-to-mid multi-million range and a lean team, there is potential to pursue partnerships with mid-sized clinics and education-focused networks to expand adoption, leverage existing tech stack, and accelerate distribution.